215 related articles for article (PubMed ID: 33502227)
1. Role of Key Guidelines in an Era of Precision Oncology: A Primer for the Radiologist.
Gan JM; Kikano EG; Smith DA; Bui MT; Tirumani SH; Ramaiya NH
AJR Am J Roentgenol; 2021 Apr; 216(4):1112-1125. PubMed ID: 33502227
[No Abstract] [Full Text] [Related]
2. Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.
Nishino M; Jagannathan JP; Ramaiya NH; Van den Abbeele AD
AJR Am J Roentgenol; 2010 Aug; 195(2):281-9. PubMed ID: 20651182
[TBL] [Abstract][Full Text] [Related]
3. Invited commentary on American College of Radiology Appropriateness Criteria endometrial carcinoma.
O'Malley R; Dighe MK
Ultrasound Q; 2014 Mar; 30(1):29-31. PubMed ID: 24901776
[No Abstract] [Full Text] [Related]
4. Radiology reporting templates in oncology: a time for change.
Kee D; Zalcberg JR
J Med Imaging Radiat Oncol; 2009 Dec; 53(6):511-3. PubMed ID: 20002280
[No Abstract] [Full Text] [Related]
5. ACR Appropriateness Criteria non-invasive clinical staging of bronchogenic carcinoma.
Ravenel JG; Rosenzweig KE; Kirsch J; Ginsburg ME; Kanne JP; Kestin LL; Parker JA; Rimner A; Saleh AG; Mohammed TL
J Am Coll Radiol; 2014 Sep; 11(9):849-56. PubMed ID: 25086958
[TBL] [Abstract][Full Text] [Related]
6. Developing Quality Measures for Diagnostic Radiologists: Part 2.
Itri JN; Raghavan K; Patel SB; Broder JC; Tierney S; Gray D; Burleson J; MacDonald S; Seidenwurm DJ
J Am Coll Radiol; 2018 Oct; 15(10):1366-1384. PubMed ID: 30170886
[TBL] [Abstract][Full Text] [Related]
7. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.
Schnipper LE; Smith TJ; Raghavan D; Blayney DW; Ganz PA; Mulvey TM; Wollins DS
J Clin Oncol; 2012 May; 30(14):1715-24. PubMed ID: 22493340
[No Abstract] [Full Text] [Related]
8. ACR Appropriateness Criteria radiologic management of hepatic malignancy.
Kouri BE; Funaki BS; Ray CE; Abou-Alfa GK; Burke CT; Darcy MD; Fidelman N; Greene FL; Harrison SA; Kinney TB; Kostelic JK; Lorenz JM; Nair AV; Nemcek AA; Owens CA; Saad WE; Vatakencherry G
J Am Coll Radiol; 2012 Dec; 9(12):919-25. PubMed ID: 23206650
[TBL] [Abstract][Full Text] [Related]
9. English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.
Hirota S; Tateishi U; Nakamoto Y; Yamamoto H; Sakurai S; Kikuchi H; Kanda T; Kurokawa Y; Cho H; Nishida T; Sawaki A; Ozaka M; Komatsu Y; Naito Y; Honma Y; Takahashi F; Hashimoto H; Udo M; Araki M; Nishidate S;
Int J Clin Oncol; 2024 Jun; 29(6):647-680. PubMed ID: 38609732
[TBL] [Abstract][Full Text] [Related]
10. Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer.
Kelley RK; Van Bebber SL; Phillips KA; Venook AP
J Natl Compr Canc Netw; 2011 Jan; 9(1):13-25. PubMed ID: 21233242
[TBL] [Abstract][Full Text] [Related]
11. Imaging surveillance of gastrointestinal stromal tumour: current recommendation by National Comprehensive Cancer Network and European Society of Medical Oncology-European Reference Network for rare adult solid cancers.
Alessandrino F; Tirumani SH; Jagannathan JP; Ramaiya NH
Clin Radiol; 2019 Oct; 74(10):746-755. PubMed ID: 31345555
[TBL] [Abstract][Full Text] [Related]
12. Cancer prevention in the era of precision oncology.
Brahme NN; Szabo E
Clin Pharmacol Ther; 2017 May; 101(5):575-577. PubMed ID: 28032900
[TBL] [Abstract][Full Text] [Related]
13. Defining precision medicine.
Burki TK
Lancet Oncol; 2017 Dec; 18(12):e719. PubMed ID: 29153736
[No Abstract] [Full Text] [Related]
14. [Tumor boards: why they are necessary and which structure is needed].
Halpern BS; Mayerhoefer ME
Radiologe; 2013 Apr; 53(4):336-40. PubMed ID: 23538997
[TBL] [Abstract][Full Text] [Related]
15. Second Opinion by In-House Radiologists: Present Picture and Emphasis on Standardizing Imaging Protocol in Oncology.
SanthoshKumar GV; Mahajan A; Desai S; Thakur M
Curr Probl Diagn Radiol; 2017; 46(5):356-359. PubMed ID: 28552548
[TBL] [Abstract][Full Text] [Related]
16. ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal Tumors.
Roberts CC; Kransdorf MJ; Beaman FD; Adler RS; Amini B; Appel M; Bernard SA; Fries IB; Germano IM; Greenspan BS; Holly LT; Kubicky CD; Lo SS; Mosher TJ; Sloan AE; Tuite MJ; Walker EA; Ward RJ; Wessell DE; Weissman BN
J Am Coll Radiol; 2016 Apr; 13(4):389-400. PubMed ID: 26922595
[TBL] [Abstract][Full Text] [Related]
17. Whole-Body MRI of the Bone Marrow: Reporting.
Moulopoulos LA; Koutoulidis V
J Magn Reson Imaging; 2019 Feb; 49(2):325-327. PubMed ID: 30548512
[No Abstract] [Full Text] [Related]
18. Response criteria in oncologic imaging: review of traditional and new criteria.
Tirkes T; Hollar MA; Tann M; Kohli MD; Akisik F; Sandrasegaran K
Radiographics; 2013; 33(5):1323-41. PubMed ID: 24025927
[TBL] [Abstract][Full Text] [Related]
19. ACR Appropriateness Criteria® posttreatment follow-up of prostate cancer.
Casalino DD; Remer EM; Arellano RS; Bishoff JT; Coursey CA; Dighe M; Eggli DF; Fulgham P; Israel GM; Lazarus E; Leyendecker JR; Nikolaidis P; Papanicolaou N; Prasad S; Ramchandani P; Sheth S; Vikram R
J Am Coll Radiol; 2011 Dec; 8(12):863-71. PubMed ID: 22137005
[TBL] [Abstract][Full Text] [Related]
20. NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.
Demetri GD; Benjamin R; Blanke CD; Choi H; Corless C; DeMatteo RP; Eisenberg BL; Fletcher CD; Maki RG; Rubin BP; Van den Abbeele AD; von Mehren M;
J Natl Compr Canc Netw; 2004 May; 2 Suppl 1():S-1-26; quiz 27-30. PubMed ID: 23573667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
